Bay Street News, November 19th, 2018

Boaz Inbal, VP R&D, will present AgPlenus’ unique approach for biology-driven discovery and introduce AgPlenus’ vision and pipeline REHOVOT, Israel, […]

CHARLOTTE, N.C., Nov. 19, 2018 (GLOBE NEWSWIRE) — Capitala Group (“Capitala” or the “Company”), a provider of capital to lower […]

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, […]

Acquires 24 percent of National Holdings’ outstanding sharesUp to an additional 32 percent of shares to be purchased following FINRA […]

ZEELAND, Mich., Nov. 19, 2018 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, […]

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous […]

Findings suggest expanded therapeutic window and significantly improved cardiovascular safety margin compared to formulation used in Phase 2b trial   […]

MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech […]

HOLLYWOOD, Fla., Nov. 19, 2018 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a professional engineering […]

WHITE PLAINS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) — SPAR Group, Inc. (Nasdaq: SGRP), a leading supplier of retail merchandising, […]